AMS is in the final stage to gain a full license to grow, market and sell medicinal cannabis products via Health Canada. BLDV has been working with AMS over the last year to finalize funding for itsFifty (50) thousand square foot cultivation facility.
"There has been recognition, by the Canadian Government, for the need to allow import and export in this industry," says Joshua B. Alper, CEO of BLDV. "This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market." "We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS.
"With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation." Canada will be the home to the new joint venture, and the first market focus will be to bring Israeli Cannabis products and technology to Canada. "AMS is the perfect partner for this project," said Joshua B. Alper, CEO of Blue Diamond Ventures, Inc. "They have a great team at AMS that has been challenged by the ever-shifting landscape of compliance and financial requirements, this project can create significant revenue even prior to AMS receiving the cultivation and manufacturing licenses from Health Canada."
LOOK HOW UNDERVALUED BLDV IS - Aurora Cannabis (Sym. ACBFF) had a $1 Bil valuation after Health Canada issued them their license to sell marijuana https://auroramj.com/investors/
BLDV currently has a $25 million mkt cap. At an equivalent mkt cap to ACBFF ... BLDV would be .21 cents (40x higher)
Market Data 
Markets 
AI
